Coral E Gartner1, Wayne D Hall2, Theo Vos1, Melanie Y Bertram1, Angela L Wallace1, Stephen S Lim1. 1. School of Population Health, The University of Queensland, Herston, Queensland, Australia. 2. School of Population Health, The University of Queensland, Herston, Queensland, Australia. Electronic address: w.hall@sph.uq.edu.au.
Abstract
BACKGROUND: Swedish snus is a smokeless tobacco product that has been suggested as a tobacco harm reduction product. Our aim was to assess the potential population health effects of snus. METHODS: We assessed the potential population health effects of snus in Australia with multistate life tables to estimate the difference in health-adjusted life expectancy between people who have never been smokers and various trajectories of tobacco use, including switching from smoking to snus use; and the potential for net population-level harm given different rates of snus uptake by current smokers, ex-smokers, and people who have never smoked. FINDINGS: There was little difference in health-adjusted life expectancy between smokers who quit all tobacco and smokers who switch to snus (difference of 0.1-0.3 years for men and 0.1-0.4 years for women). For net harm to occur, 14-25 ex-smokers would have to start using snus to offset the health gain from every smoker who switched to snus rather than continuing to smoke. Likewise, 14-25 people who have never smoked would need to start using snus to offset the health gain from every new tobacco user who used snus rather than smoking. INTERPRETATION: Current smokers who switch to using snus rather than continuing to smoke can realise substantial health gains. Snus could produce a net benefit to health at the population level if it is adopted in sufficient numbers by inveterate smokers. Relaxing current restrictions on the sale of snus is more likely to produce a net benefit than harm, with the size of the benefit dependent on how many inveterate smokers switch to snus.
BACKGROUND: Swedish snus is a smokeless tobacco product that has been suggested as a tobacco harm reduction product. Our aim was to assess the potential population health effects of snus. METHODS: We assessed the potential population health effects of snus in Australia with multistate life tables to estimate the difference in health-adjusted life expectancy between people who have never been smokers and various trajectories of tobacco use, including switching from smoking to snus use; and the potential for net population-level harm given different rates of snus uptake by current smokers, ex-smokers, and people who have never smoked. FINDINGS: There was little difference in health-adjusted life expectancy between smokers who quit all tobacco and smokers who switch to snus (difference of 0.1-0.3 years for men and 0.1-0.4 years for women). For net harm to occur, 14-25 ex-smokers would have to start using snus to offset the health gain from every smoker who switched to snus rather than continuing to smoke. Likewise, 14-25 people who have never smoked would need to start using snus to offset the health gain from every new tobacco user who used snus rather than smoking. INTERPRETATION: Current smokers who switch to using snus rather than continuing to smoke can realise substantial health gains. Snus could produce a net benefit to health at the population level if it is adopted in sufficient numbers by inveterate smokers. Relaxing current restrictions on the sale of snus is more likely to produce a net benefit than harm, with the size of the benefit dependent on how many inveterate smokers switch to snus.
Authors: Jennifer L Pearson; Amanda L Johnson; Sarah E Johnson; Cassandra A Stanton; Andrea C Villanti; Raymond S Niaura; Allison M Glasser; Baoguang Wang; David B Abrams; K Michael Cummings; Andrew Hyland Journal: Addiction Date: 2017-09-06 Impact factor: 6.526
Authors: Amanda Richardson; Jennifer Pearson; Haijun Xiao; Carolyn Stalgaitis; Donna Vallone Journal: Am J Public Health Date: 2014-06-12 Impact factor: 9.308
Authors: Karen Bogen; Lois Biener; Catherine A Garrett; Jane Allen; K Michael Cummings; Anne Hartman; Stephen Marcus; Ann McNeill; Richard J O'Connor; Mark Parascandola; Linda Pederson Journal: Harm Reduct J Date: 2009-10-19